
Am J Psychiatry 159:1935-1937, November 2002
© 2002 American Psychiatric Association
Psychopharmacologic Treatment of Generalized Anxiety Disorder and the Risk of Major Depression
Renée D. Goodwin, Ph.D., and
Jack M. Gorman, M.D.
OBJECTIVE: The authors sought to determine the association between treatment for generalized anxiety disorder and the risk of major depression among adults in the community. METHOD: Data were drawn from the National Comorbidity Survey (N=8,098), a representative sample of the United States population age 1554. Cox proportional hazards were used to determine the association between specific forms of treatment for generalized anxiety disorder and the risk of major depression. RESULTS: Psychopharmacologic treatment of generalized anxiety disorder was associated with a significantly lower risk of major depression. There was no significant association between either having seen a mental health professional for generalized anxiety disorder or having been prescribed a medication for generalized anxiety disorder and the risk of depression. CONCLUSIONS: These results suggest an association between treatment for generalized anxiety disorder and lower risk of depression, which appears specific to pharmacologic treatment. Future research that leads to a more precise delineation of the underlying mechanism of the observed association is needed to identify and develop effective strategies to prevent onset of depression.
This article has been cited by other articles:

|
 |

|
 |
 
D. J Stein
Pregabalin and venlafaxine improve symptoms of generalised anxiety disorder
Evid. Based Ment. Health,
February 1, 2007;
10(1):
23 - 23.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. M. H. Strik, J. Denollet, R. Lousberg, and A. Honig
Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction
J. Am. Coll. Cardiol.,
November 19, 2003;
42(10):
1801 - 1807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rosack
Psychiatr News,
November 1, 2002;
37(21):
26 - 26.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|